Biomedical Clause Samples
The 'Biomedical' clause defines the terms and conditions related to the use, handling, or development of biomedical materials, data, or technologies within an agreement. It typically outlines responsibilities for compliance with relevant laws and regulations, such as those governing human subjects research, biosafety, or data privacy. For example, it may specify requirements for ethical approvals, reporting of adverse events, or restrictions on the use of biological samples. The core function of this clause is to ensure that all parties adhere to legal and ethical standards in biomedical activities, thereby mitigating regulatory and reputational risks.
Biomedical. Most worksites visited lacked comprehensive HIV/AIDS related services and commodities including RH and STI kits. Following worksites requested partners, including the government to help deliver quality services to those in need. The assessment showed the imperative to address HTC demands and misconceptions associated with knowing one’s HIV status through HTC campaigns, other IEC activities, and through proper counseling and testing modalities in the worksite clinics as well as referral networks. The need to increase condom access at worksites was also revealed. Establishing linkages with surrounding care and support facilities and awareness creation activities was deemed critical as many of the worksite respondents were not willing to share meals and dorms/rooms with a person they knew had HIV.
Biomedical. In order to reach the right beneficiaries, CBHSP, key informants, and other stakeholders were involved in the preparation of monthly biomedical operational plans. The project employed 65 new biomedical providers, allocated to different districts based on targets. ▇▇▇▇▇ deployed a campaign model to reach the pediatric population at scale with HTS, and also continued engaging care and treatment (C&T) and orphans and vulnerable children (OVC) partners (Kizazi Kipya project) to reach children exposed to HIV and not yet diagnosed. Given the FY18 focus on men under 35, Sauti offered service delivery at workplaces in mining and fishing communities, local industries, trucks and taxi drivers parking stations. Sauti supported LGAs by training 132 CBHSP from 13 SNU to support index testing, adherence counseling and defaulter tracing. The project held meetings with high volume care and treatment clinics (CTCs) from 14 SNUs to discuss linkage of HIV infected beneficiaries from the community to CTC, with index testing and defaulter tracing by Sauti. Sauti is now sharing with the CTC in-charge and the C&T implementing partners (IP) the index testing report and the CTC identification number of index clients whose sexual/injecting partners and children have been tested to update family information in the CTC2 card. Based on learnings from the Population Council Project SOAR Study on the provision of Community ART to FSW and on the recently released national recommendations on the provision of Outreach ART services, Sauti started engaging the NACP and LGAs to roll out ART outreach services in select councils. In Q2, services started in Tabora and Singida, followed by Shinyanga, Dar es Salaam, Arusha and Kilimanjaro. An ART outreach orientation was rolled out within 30 regional health management teams (RHMT) and 80 council health management teams (CHMTs), with comprehensive and refresher ART and FP training to 335 and 75 government health care providers, respectively. ▇▇▇▇▇ collaborated with NACP and other IPs in developing the PrEP and HIVST national study protocol, SOPs, training curriculum and tools; and establishing a pool of 35 national facilitators. At Sauti sites, services were rolled out from May, and by mid-June all PrEP-HIVST SNUs were offering the community-based services, though only 63% of the entire HIVST supply was received. 37 RCHMT and 37 CHMT members and 128 Sauti and government health care providers were oriented through the national PrEP/HIVST...
Biomedical neurobiological, pharmacological and clinical research
Biomedical. VRI Biomedical Limited (ASX Code: VRI) is an Australian biopharmaceutical company specialising in the development and commercialisation of its world leading probiotic technology.
Biomedical. Continued supporting biomedical services at community-based HIV testing services plus (CBHTC+) sites, at home (HBTC+) and resource centers (RC); the latter until Feb 2017 when GOT requested IP to close them • Developed partner notification SOPs and tools and rolled out services at all project sites • Continued meeting and lobbying with the care and treatment implementing partners to exchange data reports on the ART cascade of HIV-infected KVP • Continued conducting internal quality control of HIV rapid tests in all regions together with the district laboratory coordinators who supplied the teams with known samples • Rolled out STI periodic presumptive treatment (PPT) in Dar es Salaam, Iringa, Njombe, and Mbeya • Supported quarterly stakeholder1 supportive supervision visits to CBHTC+, HBTC+ and RC • Supported MOHCDGEC to review STI guidelines, STI training curriculum and M&E tools, and the HTS guidelines • Participated in, and was the secretariat of, the review of the National Guidelines for Comprehensive Package of HIV Interventions for Key and Vulnerable Populations 2014, and provided technical assistance during the workshops on ART-differentiated service delivery models • Provided technical assistance to MOHCDGEC by reviewing the Health Sector HIV/AIDS Strategic Plan III (2012-2017) and contributing to the development of the Health Sector HIV/AIDS Strategic Plan IV (2018-2020). • Regularly participated in the FP technical working group (TWG) and FP training subcommittee technical meeting both chaired by Reproductive, Child Health Section (RCHS) of MOHCDGEC • Rolled out FP training to 18 biomed team and conducted on-the-job training on use of Implanon NXT to 55 biomed providers • Rolled out of focus group discussion on PrEP, CTC Linkage and Partner notification • Intensified supportive supervision to the regions with low performance - i.e., Mbeya, Shinyanga, Tabora, Mtwara, and Singida • Introduced community ART study to R/CHMT and started service delivery in Njombe region (project SOAR/Pop Council); cumulatively enrolled 233 FSW into community ART within the first 38 days of operation, across four councils – reference to Figure 7 below • Drafted HIVST and PrEP SOPs and tools, and participated in the development of the national PrEP protocol • Developed SBCC curricula evaluation SOP and tools, rolled out the evaluation; report being under development • Finalized and rolled out the Gender, Sexuality, and gender-based violence (GBV) curriculum to all proje...